P/E ratio for Biocon (BIOCON.NS)
P/E ratio as of April 2024 (TTM): 81.0
According to Biocon's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 81.0301. At the end of 2022 the company had a P/E ratio of 80.6.
P/E ratio history for Biocon from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 80.6 | 23.07% |
| 2021 | 65.5 | -27.56% |
| 2020 | 90.4 | 117.54% |
| 2019 | 41.5 | -8.07% |
| 2018 | 45.2 | -47.33% |
| 2017 | 85.8 | 276.34% |
| 2016 | 22.8 | -8.16% |
| 2015 | 24.8 | 21.51% |
| 2014 | 20.4 | 23.75% |
| 2013 | 16.5 | 6.2% |
| 2012 | 15.5 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.